Baquero F
Department of Microbiology, Ramón y Cajal Hospital, Madrid, Spain.
Clin Infect Dis. 1996 Oct;23(4):819-23. doi: 10.1093/clinids/23.4.819.
The document Antibiotic Resistance in Spain: What Can Be Done? was prepared in 1994 by an ad hoc Task Force under the auspices of the Spanish Ministry of Health. The problem of the development of antibiotic resistance in community-acquired bacterial pathogens in Spain and its relation to antibiotic use and consumption has been of both national and international concern. This document analyzes the problem and provides general recommendations for limiting the emergence, evolution, and spread of resistant microorganisms. Particular emphasis is given to systems for surveillance of antibiotic resistance, the monitoring of patterns of antibiotic use and consumption, and strategies for influencing the producers (pharmaceutical industry), prescribers (physicians and veterinarians), dispensers (pharmacists), and consumers (patients) of antibiotics. Control of the emergence of antibiotic resistance requires a concerted effort on the part of all social and scientific agencies involved in health care.
《西班牙的抗生素耐药性:能做些什么?》这份文件由一个特别工作组于1994年在西班牙卫生部的主持下编制。西班牙社区获得性细菌病原体中抗生素耐药性的发展问题及其与抗生素使用和消费的关系一直是国内和国际关注的焦点。本文献分析了该问题,并提出了限制耐药微生物出现、演变和传播的一般性建议。特别强调了抗生素耐药性监测系统、抗生素使用和消费模式监测以及影响抗生素生产商(制药行业)、开处方者(医生和兽医)、配药者(药剂师)和消费者(患者)的策略。控制抗生素耐药性的出现需要所有参与医疗保健的社会和科学机构共同努力。